Nuvation Bio (Nuvation Bio) Other Long Term Assets : $0.73 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Nuvation Bio Other Long Term Assets?

Nuvation Bio's other long-term assets for the quarter that ended in Dec. 2023 was $0.73 Mil.

Nuvation Bio's quarterly other long-term assets increased from Jun. 2023 ($0.14 Mil) to Sep. 2023 ($0.73 Mil) and increased from Sep. 2023 ($0.73 Mil) to Dec. 2023 ($0.73 Mil).

Nuvation Bio's annual other long-term assets declined from Dec. 2021 ($0.42 Mil) to Dec. 2022 ($0.14 Mil) but then increased from Dec. 2022 ($0.14 Mil) to Dec. 2023 ($0.73 Mil).

Nuvation Bio Other Long Term Assets Historical Data

The historical data trend for Nuvation Bio's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuvation Bio Other Long Term Assets Chart

Nuvation Bio Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

0.42

0.14

0.73

Nuvation Bio Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Long Term Assets	Get a 7-Day Free Trial											0.14	0.14	0.14	0.73	0.73

Nuvation Bio Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Nuvation Bio (Nuvation Bio) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuvation Bio Inc (NYSE:NUVB.WS) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

NUVB:USA

Address

1500 Broadway, Suite 1401, New York, NY, USA, 10036

Website

https://www.nuvationbio.com

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's clinical-stage product candidate is NUV-868, a BD2-selective oral small molecule BET inhibitor. NUV-868 inhibits the protein BRD4, a key member of the BET family that epigenetically regulates a number of important proteins that control tumor growth and differentiation, including oncogenes such as c-myc. Notably, BET proteins have critical biological functions and are found to be altered in many human cancers. It is also developing its proprietary, small molecule Drug-Drug Conjugate (DDC) platform, a novel therapeutic approach within the drug-conjugate class of anti-cancer therapies with parallels to Antibody-Drug Conjugates (ADCs).